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Abstract
Background: Early diagnosis and immediate initiation of treatment are essential for an effective
tuberculosis (TB) control program. Delay in diagnosis is significant to both disease prognosis at the
individual level and transmission within the community. Most transmissions occur between the
onset of cough and initiation of treatment.
Methods: A systematic review of 58 studies addressing delay in diagnosis and treatment of TB was
performed. We found different definitions of, for example, debut of symptoms, first appropriate
health care provider, time to diagnosis, and start of treatment. Rather than excluding studies that
failed to meet strict scientific criteria (like in a meta-analysis), we tried to extract the "solid findings"
from all of them to arrive on a more global understanding of diagnostic delay in TB.
Results: The main factors associated with diagnostic delay included human immunodeficiency
virus; coexistence of chronic cough and/or other lung diseases; negative sputum smear;
extrapulmonary TB; rural residence; low access (geographical or sociopsychological barriers);
initial visitation of a government low-level healthcare facility, private practitioner, or traditional
healer; old age; poverty; female sex; alcoholism and substance abuse; history of immigration; low
educational level; low awareness of TB; incomprehensive beliefs; self-treatment; and stigma.
Conclusion: The core problem in delay of diagnosis and treatment seemed to be a vicious cycle
of repeated visits at the same healthcare level, resulting in nonspecific antibiotic treatment and
failure to access specialized TB services. Once generation of a specific diagnosis was in reach, TB
treatment was initiated within a reasonable period of time.
Background
Until the last part of the twentieth century, tuberculosis
(TB) was a major cause of death in both developed and
developing countries. Due to a range of factors such as the
human immunodeficiency virus (HIV) epidemic, popula-
tion growth, migration, socioeconomic changes, and
broad spread of aggressive and resistant new strains such
as the Beijing and W strains, a resurgence of TB has
occurred, even in low endemic areas [1]. In 1993, the
World Health Organization (WHO) declared a state of
global emergency for TB due to the steady worldwide
increase in the disease. Along with HIV and malaria, TB
has been declared a global enemy. In 2005, 12 million
new cases of tuberculosis were identified, a 58% increase
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estimated that in 2005 the disease caused 1.5 million
deaths worldwide [2].
The goal of TB control programs is to arrest transmission
within the community. Achieving this goal takes consider-
able time, because most individuals in endemic areas are
already infected, constituting a reservoir that continu-
ously contributes to the pool of infectious cases. An effec-
tive TB control program requires early diagnosis and
immediate initiation of treatment. Delay in diagnosis is
significant with regard to not only disease prognosis at the
individual level but also transmission within the commu-
nity and the reproductive rate of the TB epidemic [3,4].
Most transmissions occur between the appearance of
cough and initiation of treatment. Madebo et al found
that patients become more contagious as the delay
progresses; the longest delays are associated with the high-
est bacillary numbers on sputum smears [5]. Because TB
symptoms, particularly chronic cough with sputum, are so
prevalent in most societies, early contact with health serv-
ices causes delay rather than suspicion of TB. We found
that in Ethiopia patients with TB symptoms contact an
educated health worker on average after just 25% of the
total delay period [6]. Thus, there is a fourfold-difference
in the time of first contact and diagnosis.
Analysis of the factors leading to this delay between first
contact and diagnosis is crucial to combatting the increas-
ing TB epidemic. Although there are multiple studies of
delayed TB diagnosis, no one has performed a systematic
review.
Methods
Search strategy
We searched the following databases using the search
terms and strategy described in Table 1: the Cochrane
Infectious Diseases Group Specialized Register (February
2007); the Cochrane Central Register of Controlled Trials
(CENTRAL) published in The Cochrane Library (February
2007); MEDLINE (1966 to February 2007); EMBASE
(1974 to February 2007); and LILACS (1982 to February
2007). In addition, to identify unpublished and ongoing
studies, we contacted individual researchers in the TB field
as well as the WHO (2006) and the International Union
Against Tuberculosis and Lung Disease (IUATLD, 2006).
Selection and analysis
Only observational studies were selected. All obtainable
studies of patients receiving treatment for active pulmo-
nary TB that recorded at least the median or mean total
delay in diagnosis were included. The outcomes of inter-
est were diagnostic delay from the debut of symptoms to
the time of diagnosis or start of treatment. The titles and
abstracts of the identified reports were used to exclude
studies that clearly did not meet the inclusion criteria. For
studies deemed potentially eligible for inclusion, we
obtained the full paper. We screened the full articles of
selected studies to confirm eligibility and resolved any dis-
agreements by discussion. Our intent was not to exclude
studies based on strict scientific criteria, or to perform a
traditional quality assessment, but to make the studies as
comparable as possible.
We analyzed the studies with the intent of identifying dif-
ferences in approaches, rather than to define a gold stand-
ard. A primary aim was to describe the inevitable
inaccuracy that arises from the use of different definitions
of, for example, the debut of symptoms, first appropriate
health care provider, time of diagnosis, and start of treat-
ment.
Results
Search results
Our analysis revealed how complex it is to define diagnostic
delay, and there were major differences between studies
regarding inclusion and exclusion criteria, onset of symp-
toms, first contact and end of delay. First, the 58 studies
used different inclusion criteria. Seventeen studies included
all new TB cases, 11 included all pulmonary TB cases, 3
included all cases with a positive sputum smear, 24
included all new cases with a positive sputum spear, and for
3 studies data were not obtainable. Likewise, the study
exclusion criteria differed. Some studies carefully excluded
Table 1: Search terms and strategy
Search set CIDG SR CENTRAL MEDLINE EMBASE LILACS
1 Tuberculosis Tuberculosis Tuberculosis Tuberculosis Tuberculosis
2 Diagnostic delay Diagnostic delay Diagnostic delay Diagnostic delay Demora diagnostico*
3 Treatment delay Treatment delay Treatment delay
4 Treatment seeking Treatment seeking Treatment seeking
5 Case finding Case finding Case finding
6 Help seeking Help seeking Help seeking
CIDG SR: Cochrane Infectious Diseases Group Specialized Register
CENTRAL: Cochrane Central Register of Controlled Trials
*Demora diagnostico: Diagnostic delayPage 2 of 9
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that could interfere with the patient's definition of symp-
tom onset, but most did not. Some studies excluded visi-
tors, mortal cases, and individuals with mental
disturbances. The age-related exclusion criteria also varied:
most studies excluded cases below the age of 16 years, some
excluded cases below the age of 18 years, and a few included
children of all ages. One study did not include patients who
had undergone 2 or more months of treatment.
Definition of the onset of symptoms was also variable.
Forty-nine studies defined onset as the debut of any symp-
tom, 2 studies defined onset as debut of cough, and 1
study defined onset as debut of any pulmonary symptom.
For 6 studies, a definition of symptom onset could not be
obtained.
With regard to definition of the first contact, 34 studies
defined the first contact as the first visit to a qualified
healthcare provider. However, some of these studies
included any allopathic ("western medicine") provider
within the category of a qualified healthcare provider; oth-
ers used the time of first contact with the national TB pro-
gram in defining the end of patient delay. Eighteen studies
defined the first contact as the time when the patient
sought contact with any healthcare provider outside the
household, including traditional practitioners. Four stud-
ies recorded both. Six studies did not provide any infor-
mation with regard to definition of the first contact.
The studies also applied different definitions of the end of
the delay. Seventeen studies defined the end of healthcare
system delay as the time when a correct diagnosis was
made (diagnostic delay), 20 studies defined it as the time
the patient started treatment (treatment delay), and 14
studies distinctly recorded both. Data of this kind were
unavailable for 7 studies.
Most studies defined the delay as a specific number of
days, but several studies defined it as greater than a spe-
cific period of time (e.g. >60 days, > 90 days), or delay was
defined as significantly longer in one group versus
another group. A cut off point of 30 days to dichotomize
into either delay on non delay was also commonly used.
Diagnostic delay
Table 2 lists the included studies in descending order
according to the total diagnostic delay. Not surprisingly,
the longest total delays (> 120 days) were reported for
some high endemic countries, with the exception of the
median 126-day delay reported by Lewis et al for East Lon-
don [7]. Most of the studies, whether investigating low or
high endemic countries, reported a total diagnostic delay
within the range of 60–90 days (mean ± standard devia-
tion: 72 days ± 28 days).
There was no consistent pattern with regard to the relative
contributions of patients and healthcare providers to the
diagnostic delay. The main delay was patient related in the
studies in London (Lewis et al), Romania, Vietnam,
Nigeria, South Africa, Australia (Queensland), Ethiopia
(Addis Abeba), Korea, Somalia, Syria, Turkey (Istanbul,
Okur et al), Japan (Chiba), Iraq, USA (New York), Yemen,
and China (Shanghai). The main cause of delay was iden-
tified as the healthcare system in the studies of Tanzania,
Ghana, Pakistan, Malaysia, Iran (WHO, nationwide), Bot-
swana, New Zealand, Uganda, Ethiopia (Amhara), Italy,
and China (Jianhu). Twelve studies reported a nearly
equal contribution of patients and healthcare system to
the diagnostic delay. The remaining studies did not record
the relative importance of these two factors in the diag-
nostic delay.
Symptoms prior to diagnosis
Twenty-five studies recorded the frequency of symptoms
reported by patients before diagnosis. The average fre-
quencies of the following five cardinal symptoms were
(number of studies listing the symptom in brackets):
cough 85% (25), fever 65% (24), weight loss 62% (22),
chest symptoms 50% (24), and haemoptysis 25% (22).
Other symptoms less frequently reported: sputum 67%
(5), fatigue 55% (8), and increased sweating 35% (10).
All but two studies defined the onset of patient delay from
the debut of any symptom [8,9], where the debut of cough
defined the start.
Risk factors for prolonged diagnostic delay
The possible risk factors for diagnostic delay were hetero-
geneous (Table 3). The study conclusions were also heter-
ogeneous; a risk factor for increased delay in some studies
was a risk factor for decreased delay in other studies. Some
factors were identified in numerous studies, while others
were mentioned by only one study or a few studies. Fol-
lowing is a brief analysis of the factors, which are further
elaborated in the "Discussion".
Clinical characteristics
The WHO study in Syria found HIV to be a risk factor for
increased delay in diagnosis [10], while three other stud-
ies concluded the opposite [11-13]. Four studies found
coexistence of chronic cough and/or other lung diseases
be a risk factor for increased delay [12,14-16]; one study
found the opposite [7]. Only a few studies included
extrapulmonary TB, and as expected three found that
patients with extrapulmonary TB experience longer delays
than do patients with pulmonary TB [7,17,18]. Three
studies found a negative sputum smear to be a risk factor
for increased delay [12,19,20]; one study found the oppo-
site (the WHO study in Egypt [15]). Six studies found
alcoholism or substance abuse to be a risk factor for
increased diagnostic delay [8,21-25]. Other health-relatedPage 3 of 9
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Country Year First author DD Pat DD HCP DD total Ref no.
Tanzania 2000 Wandwalo 15 120 136 [29]
United Kingdom 2003 Lewis 63 35 126 [7]
Burkina Faso 2006 Ouedraogo * * 120 [49]
Ethiopia 1999 Madebo * * 120 [5]
Ghana 1998 Lawn 28 56 120 [11]
Malawi 1988 Nkhoma * * 120 [54]
Thailand 1991 Tesana * * 120 [55]
Thailand 1993 Pungrassami * * 120 [45]
Romania 1989 Anastasatu 69♠ 34♠ 107♠ [33]
Iran 2002 Masjedi 13♠ 93♠ [51]
Vietnam 1999 Long 54♠ 29♠ 93♠ [30]
Pakistan 2006 WHO 9 87 91 [27]
Malaysia 1994 Hooi 15 35 90 [21]
United States 2005 Golub 32 26 89 [22]
Iran 2006 WHO 24 42 88 [27]
Malaysia 1997 Liam 14 49 88 [36]
Botswana 1998 Steen 21 35 84 [26]
New Zealand 2000 Calder 7 49 84 [44]
Uganda 2005 Kiwuwa 14 63 84 [23]
Spain 2003 Altet Gomez 43♠ 39♠ 82♠ [24]
Ethiopia 2005 Yimer 15 61 80 [6]
Nepal 2001 Yamasaki-Nakagawa 23 29 79 [14]
Japan 1990 Niijima * * 78† [46]
Mongolia 1996 Enkhbat 29 35 78 [35]
Nigeria 2004 Odusanya 56 7 70 [19]
South Africa 2001 Pronyk 28 7 70 [8]
Australia 2001 Ward 30 11 66 [20]
Thailand 2006 Rojpibulstit 31 20 66 [9]
China 2004 Bai 30 24 65 [28]
Italy 2006 Gagliotti 7 36 65 [38]
Spain 1996 Franco 23 32 64 [12]
Turkey 2004 Güneylioglu 18♠ 13♠ 64♠ [16]
Ethiopia 2002 Demissie 60 6 64 [18]
Norway 2006 Farah 28 33 63 [17]
United States 1998 Asch 60s [42]
India 2002 Rajeswari 20 23 60 [25]
Korea 1992 Mori 54♠ 14♠ 60♠ [31]
Peru 1996 Chavez * * 60 [53]
The Gambia 2001 Lienhardt * * 60 [32]
Zambia 2001 Needham * * 60 [10]
Cambodia 2006 Saly * 10 58 [50]
Somalia 2006 WHO 53 7 58 [27]
Malawi 2000 Salaniponi * * 56 [47]
Syria 2006 WHO 31 15 55 [27]
China 2005 Xu 10 39 50 [37]
Turkey 2006 Okur 30 19 49 [34]
United Kingdom 2007 Rodger * * 49 [40]
Australia 1996 Pirkis * * 44 [15]
Taiwan 2005 Chiang 7 23 44 [56]
Egypt 2004 WHO 12 18 42 [27]
Japan 2002 Sasaki 21 7 42 [52]
Iraq 2004 WHO 31 2 36 [27]
United States 1999 Sherman 21 6 35 [39]
Yemen 2004 WHO 28 4 35 [27]
China 2006 Deng 19 5 31 [41]
France 1996 Gulbaran 30♠ [48]
Thailand 2001 Ngamvithayapong 11 8 * [13]
Pakistan 2001 Sadiq 21€ [57]Page 4 of 9
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Table 3: Risk factors for diagnostic delay
Risk factor Positive association with risk Negative association with risk
HIV [10] [11-13]
Coexistence of chronic cough and/or other 
lung diseases
[12, 14-16] [7]
Negative sputum smear [12, 19, 20] [15]
Extrapulmonary TB [7, 17, 18]
Rural residence [5, 11, 14, 16, 23, 25, 29-32]
Low access to healthcare (geographical or 
socio-psychological barriers)
[6, 8, 10, 14, 18, 23, 25, 27-30, 34, 42, 47, 48, 
50]
Initial visit to government low-level healthcare 
facility
[5, 6, 9-11, 23, 26, 32-34] [35]
Initial visit to traditional or unqualified 
practitioner
[9, 10, 14, 26-29, 32, 36, 37]
Initial visit to private practitioner [9, 10, 14, 26-29, 32, 36, 37]
Initial visit to tertiary-level services/hospital [11] [13, 23, 38, 39]
Old age [5, 12, 14-16, 19, 23, 24, 26, 38, 40, 41] [18, 35]
Poverty [7, 20, 21, 27, 28, 34, 37, 40, 41, 47, 48, 54, 56] [18]
Female sex [8, 10, 11, 14-16, 20, 22, 31, 33, 39, 40] [5, 21, 23, 25]
Alcoholism or substance abuse [8, 21-25]
History of immigration [8, 15, 17, 22, 38, 39, 42]
Low educational level and/or low awareness 
and knowledge about TB
[9, 15-17, 20, 21, 23, 24, 27, 28, 31-33, 38, 39] [13] (low educational level)
Other Health-related reasons:
Generally poor health [26]
Smoking [14, 23]
Coexistence of sexually transmitted diseases [26]
Less severe and indifferent symptoms [27]
No haemoptysis [16, 28]
Socioeconomic factors:
Married [5]
Single [18, 26]
Large family size [30]
Farmer [5]
White (vs. aboriginal) [20]
Muslim [18]
Belonging to an indigenous group [13]
No insurance [13]
Beliefs and attitudes:
Beliefs about TB (not curable, caused by evil spirits, etc.) [8, 14, 27]
Stigma [27]
Self-treatment [6, 36, 42]
The columns are identifying the applicable studies finding positive and negative association, respectively, with the risk factorsrisk factors identified include generally poor health [26],
smoking [14,23], coexistence of sexually transmitted dis-
eases [26], less severe and indifferent symptoms [27], and
absence of hemoptysis [16,28].
Socioeconomic factors
A range of studies found rural residence to be a risk factor
for prolonged delay [5,11,14,16,23,25,29-32]. This risk
factor seems to be closely linked to low access to health-
care and choice of settings in which to first seek healthcareThe studies are listed in descending order of the median diagnostic delay.
DD Pat (Diagnostic Delay by the Patients): Time from debut of symptoms to first visit to health care provider
DD HCP (Diagnostic Delay by the Health Care Providers): Time from first visit to a HCP to the making of a proper diagnosis
DD Total (Total Diagnostic Delay): Time from debut of symptoms to the making of a proper diagnosis
* Data not obtainable
† Average calculated by the reviewers from separate numbers for female and male
♠ Mean
s 80% percentile
€ 77% percentile
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access to healthcare varied. For example, in Ethiopia the
public health service coverage was reported to be 50% [6],
whereas in The Gambia 87% of the population was
reported to have good access to healthcare [7,19,20,32].
The studies provided broad evidence that low access leads
to prolonged delay in diagnosis [5,7,9,13,17,20,27-33].
Sociopsychological factors
Seeking government low-level health care facility first
[5,6,9-11,23,26,32-34] (one study from Spain found the
opposite [35]). Initially seeking a traditional or unquali-
fied practitioner [9,10,14,26-29,32,36,37]. First seeking a
private practitioner was a clear risk factor for diagnostic
delay, independent of rural or urban residence [9-
11,14,15,19,21,23,24,26,28,35]. Four studies concluded
that seeking specialized services leads to a decreased diag-
nostic delay [13,23,38,39], while one study from the USA
[11] found the opposite.
Sociodemographic factors
A range of studies found old age to be a risk factor for
increased diagnostic delay [6,13,15-17,20,23,25,32,37-
39], while two studies found the opposite [18,35]. Also, a
number of studies concluded that females experience
increased diagnostic delay [8,10,11,14-
16,20,27,28,30,40,41]. However, a substantial number of
studies made the opposite conclusion [5,21,23,25]. In
addition, history of immigration or illegal residency
seemed to be a risk factor in countries where this is actual
[8,15,17,22,38,39,42].
Socioeconomic factors
Thirteen studies found low income and poverty to be a
risk factor for diagnostic delay
[3,7,17,23,24,31,34,38,39,43-46]. In a range of studies,
low educational level and/or low awareness and knowl-
edge about TB was listed as a risk factor for diagnostic
delay [5,10,16-18,21,23,25,27-29,34,37,47,48]. Only
one, from France [13], determined the opposite, finding
that low educational level was linked to immigration and
socially deprived groups where the health authorities
focused on TB.
Other socioeconomic risk factors identified by 1–3 studies
included being married [5], being single [18,26], large
family size [30], being a farmer [5], being white (vs. abo-
riginal) [20], being a Muslim [18], belonging to an indig-
enous group [13], and not having insurance [13].
Beliefs and attitudes
Beliefs about TB (TB is incurable, caused by evil spirits,
etc.) [8,14,27], stigma [27], and self-treatment [6,36,42]
were identified as risk factors in 1–3 studies.
The vicious circle of repeated visits at the same level
A majority of the studies identified as the direct or under-
lying problem a vicious circle of repeated consultations
with a multitude of healthcare providers without a correct
diagnosis. Several papers list multiple visits at the same
level, while others focus on multiple visits to the same
physician. Three groups of healthcare providers were par-
ticularly identified as sources of this vicious circle: pri-
mary-level government health posts, who have limited
diagnostic facilities and poorly trained personnel [5,6,9-
11,23,26,32-34]; private practitioners with low awareness
of TB [9-11,14,15,19,21,23,25,26,29,32]; and unquali-
fied vendors, quacks, and traditional practitioners
[9,10,14,26-29,32,36,37] In Burkina Faso for a patient
seeking a health post or a private practitioner, the progres-
sion towards specialized services was poor; patients had
repeated consultations at the same level, such that more
than 94% of patients underwent repeated courses of non-
specific antibiotics [49]. In Ghana, the health personnel
at government health posts have poor training in diagnos-
ing TB, and the specialized services of the NTP are over-
centralized [11]. In a study in Malaysia, only 11% of
patients received their diagnosis after the first consulta-
tion, and 45% received their first diagnosis after the third
consultation [21]. Another study from Malaysia similarly
indicates low awareness of the private practitioner as a key
problem [36].
Discussion
The studies had different definitions of a range of varia-
bles, for example, debut of symptoms, first appropriate
health care provider, time to diagnosis, and start of treat-
ment, and they were not directly comparable or suited for
a meta-analysis. Rather than excluding studies that failed
to meet strict scientific criteria (like in a meta-analysis), we
tried to extract the "solid findings" from all of them to
arrive on a more global understanding of diagnostic delay
in TB. Our detailed analysis demonstrates that the inter-
acting factors affecting patients' health-seeking behavior
and the availability of TB treatment can be categorized as
involving either the patient or healthcare. Most factors
influence both patient and health care delay, but some
factors were more closely related to patient delay: alcohol
or substance abuse, poverty, low access to health care
facilities, rural residence, old age, belonging to an indige-
nous group and incomprehensive attitudes, beliefs and
knowledge about TB. Other factors were evidently more
linked to health care delay: coexistence of chronic cough
and/or other lung diseases, having extrapulmonary or
negative sputum smear TB, less severe and indifferent
symptoms or absence of haemoptysis, poor health care
infrastructure and seeking traditional and private practi-
tioners first. As patients continue to go untreated, absent
isolation, both components equally contribute to the
infectious pool.Page 6 of 9
(page number not for citation purposes)
BMC Public Health 2008, 8:15 http://www.biomedcentral.com/1471-2458/8/15Our analysis revealed that the vicious circle of repeated
visits at the same level is the core problem of diagnostic
delay in most high endemic countries. TB is a rare disease,
and more than 95% of patients with chronic cough seek-
ing treatment at the level of primary healthcare do not
have TB [43]. The delay in diagnosis on the part of health
providers does not necessarily reflect inferior perform-
ance, but instead a lack of effective diagnostic tools and
follow-up routines. Correct diagnosis requires both good
training and available diagnostic facilities. The number of
repetitions of this vicious cycle proved to be highly
dependent on both the patient's beliefs and awareness of
TB and the category of healthcare provider. In most coun-
tries, private practitioners are consulted first, and this pat-
tern is significantly associated with a longer diagnostic
delay. This pattern is also recognized as a source of bottle-
neck in low endemic countries. A New Zealand study
observed that the first consulting doctor often did not per-
form an X-ray, ask about previous TB, or obtain a sputum
smear – although the patients had classical symptoms
[44]. The same observations were make by Ward et al in
Australia [20]. Cough was treated symptomatically, and
CXR were misdiagnosed.
A range of studies have shown that selection of a tradi-
tional practitioner for the first visit is associated with a
prolonged delay in diagnosis [9,10,14,26-29,32,36,37].
In Yimer et al's study from Ethiopia, patients who first vis-
ited a qualified medical provider experienced a 21-day
delay before initiation of treatment. Patients who first vis-
ited a traditional healthcare provider waited 15 days
before first seeking healthcare, but the period from first
visit to initiation of TB treatment was 4-fold greater [6].
These findings are supported by studies of The Gambia
[32], Tanzania [29], and Penang [21].
Many studies describe a bottleneck in reaching the local
unit of the NTP. Multiple studies observed poor access to
the NTP as one of the main factors in delayed diagnosis
[6,8,10,14,18,23,25,27-30,34,42,47,48,50]. In many
high endemic countries, it appears crucial that a unit of
the NTP is within a 1-day walking distance, as many
patients have limited access to motorized vehicles. In
addition to geographic distance, the studies identified sev-
eral other barriers. One of the most important barriers is
stigma [27]. Many patients were highly reluctant to visit
the NTP facility, because it would mean disclosing to the
public that they had TB. Even worse, in many countries,
TB is so closely linked to HIV that patients fear they are
revealing HIV status to their neighbors [37]. Also, many of
the NTP personnel are unfriendly. Many patients feel
deprived of both privacy and dignity. The widespread
introduction of DOTS also means that patients must visit
daily so that their consumption of medication can be
directly observed; this is perceived as humiliating, time
consuming, and a threat of a substantial loss of income
[6,51,52]. A marginal farmer or a day laborer will often
have to choose between treatment and placing food on
the table for his family. Most of the studies from develop-
ing countries demonstrated a significant link between
delayed diagnosis and poverty
[7,20,21,27,28,34,37,40,47,48].
Most of the studies in our review also demonstrate the
nonspecific nature of symptoms and the disease's first nat-
ural history as a core problem [15,18,23,31,50,53]. In the
Gambia, TB is often misdiagnosed as malaria or viral
infections [32].
Several studies also highlight the problem of self-treat-
ment [6,36,42]. In the study in Pakistan, more than 50%
of patients practiced self-treatment, and 42% first
searched a pharmacy for their symptoms[27]. Many stud-
ies link this to the problem of stigma, in fact the unhappy
triad of incomprehensive beliefs, low awareness, and
stigma.
Conclusion
Our analysis is consistent with the findings of the WHO
Eastern Mediterranean Region study. They concluded:
"The private sector was the first choice for more than two-
thirds of the patients. The main determinants of delay
were: socio-demographic; economic; stigma; time to
reach the health facility; seeking care from non-special-
ized individuals; and visiting more than one health care
provider before diagnosis [3]." The core problem in delay
of diagnosis and treatment seemed to be a vicious cycle of
repeated visits at the same healthcare level, resulting in
nonspecific antibiotic treatment and failure to access spe-
cialized TB services. Once generation of a specific diagno-
sis was in reach, TB treatment was initiated within a
reasonable period of time.
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